Health In Tech, Inc. (HIT) · Oct 26, 2026 · Exec change
CEO transition — Sanjay Shrestha replaces founder Tim Johnson as CEO
Health In Tech’s CEO change puts operations under Sanjay Shrestha while founder Tim Johnson stays involved; the equity package ties rewards to growth milestones.
Health In Tech is an AI-enabled insurance marketplace trying to turn its HitRix platform and carrier relationships into broader commercial adoption; its recent operating challenge is execution and scale, not simply product creation.
The transition separates founder vision from day-to-day execution. Sanjay Shrestha becomes CEO while founder Tim Johnson moves to Executive Chairman, leaving Johnson focused on strategy, technology and product development while Shrestha owns operating performance, commercial execution and potential acquisitions. 〔0〕
The incentive package is designed around a much larger growth story, but it is not evidence that the growth has arrived. The filing grants or proposes up to 8 million shares across sign-on, acquisition and market-capitalization awards, with milestones ranging from a market capitalization above $150 million by April 30, 2028, to above $1 billion by December 31, 2031. The largest unissued tranches depend on shareholder approval, and the structure creates meaningful potential dilution if those hurdles are ultimately met. 〔1〕
This does not yet prove a turnaround or resolve the company’s governance pressure. The filing supplies no new revenue, profitability or operating target, and its own risk disclosure still identifies the need to regain and maintain Nasdaq compliance; that matters because Nasdaq recently notified Health In Tech that it was out of compliance with board-independence and audit-committee requirements.
The news itself is mostly confirmation, not a fresh surprise. The CEO appointment and founder transition were announced effective October 20, 2026, six days before this 8-K was filed, so the filing mainly adds the employment and equity-award mechanics rather than changing the leadership narrative. 〔2〕
Bottom line: This is a planned management reshuffle aimed at converting Health In Tech’s technology platform into commercial growth, with founder continuity preserved. It improves accountability for execution but is not, by itself, operating proof—and the shareholder vote makes the equity package the immediate next test.
Shareholder vote on equity-plan expansion, November 10, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!